26 September 2022
ECO Animal Health Group plc ("the Company")
(AIM: EAH)
Result of Annual General Meeting
ECO Animal Health Group plc announces that at its Annual General Meeting held earlier today ("AGM") all resolutions proposed to the meeting were duly passed.
Proxy votes received in relation to each resolution were as follows:
| Resolution | For |
% |
Discretionary |
% | Against |
% | Withheld |
| 01 | 41,113,787 |
86.2178 |
30,535 |
0.0640 | 6,541,662 |
13.7182 | Nil |
| 02 | 47,645,198 |
99.9354 |
30,535 |
0.0640 | 251 |
0.0005 | 10,000 |
| 03 |
47,655,198 |
99.9354 |
30,535 |
0.0640 | 251 |
0.0005 | Nil |
| 04 | 47,632,825 |
99.8885 |
30,535 |
0.0640 | 22,624 |
0.0474 | Nil |
| 05 | 40,913,787 |
85.7983 |
19,007 |
0.0398 | 6,753,190 |
14.1618 | Nil |
| 06 | 47,644,711 |
99.9139 |
30,535 |
0.0640 | 10,487 |
0.0219 | 251 |
| 07 | 47,646,815 |
99.9304 |
30,535 |
0.0640 | 2,633 |
0.0055 | 6,001 |
|
08 | 47,642,165 |
99.9102 |
30,535 |
0.0640 | 12,283 |
0.0258 | 1,001 |
Contacts:
| ECO Animal Health Group plc David Hallas (CEO) Christopher Wilks (CFO)
|
|
| IFC Advisory Graham Herring Zach Cohen
| 020 3934 6630
|
| Singer Capital Markets (Nominated Adviser & Joint Broker) Mark Taylor George Tzimas
| 020 7496 3000 |
| Investec (Joint Broker) Gary Clarence Brough Ransom Carlo Spingardi
| 020 7597 5970 |
| Peel Hunt LLP (Joint Broker) Dr Christopher Golden | 020 7418 8900 |
James Steel
| Equity Development Hannah Crowe Matt Evans | 020 7065 2692 |
About ECO Animal Health
ECO Animal Health Group plc researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new products
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
